Open AccessComparison of Outcomes Among Patients Randomized to Warfarin Therapy According to Anticoagulant Control
Author(s) -
Harvey D. White
Publication year - 2007
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.167.3.239
Subject(s) - medicine , warfarin , atrial fibrillation , stroke (engine) , randomized controlled trial , myocardial infarction , cardiology , embolism , mechanical engineering , engineering
Warfarin sodium reduces stroke risk in patients with atrial fibrillation, but international normalized ratio (INR) monitoring is required. Target INRs are frequently not achieved, and the risk of death, bleeding, myocardial infarction (MI), and stroke or systemic embolism event (SEE) may be related to INR control.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom